Collectively, these results indicated that the TIM-3 and PD-1 blockades reversed the immunosuppressive TME of mice with HPD, mediated by the activation of CD8+ T cells and TIDCs, which enhanced the anti-tumor immunity. Here, CD8A is linked to neoplasm.